Series B - Revolo Biotherapeutics
Investment Firm
Overview
Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing.
Announced Date
Sep 21, 2020
Funding Type
Series B
Highlights
Location
Europe
Social
Participant Investors
3
| Investor Name |
|---|
 24 Haymarket |
Round Details and Background
Revolo Biotherapeutics raised $52045143 on 2020-09-21 in Series B
Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 22, 2018 |  Series A - Revolo Biotherapeutics | 2 | - | undefined |
| Sep 21, 2020 | Series B - Revolo Biotherapeutics | 3 | - | 52.0M |
Recent Activity
There is no recent news or activity for this profile.